Prediction of Upcoming Global Infection Burden of Influenza Seasons After Relaxation of Public Health and Social Measures During the COVID-19 Pandemic: a Modelling Study

Overview

Journal Lancet Glob Health

Specialty Public Health

Date 2022 Oct 14

PMID 36240828

Authors

Sheikh Taslim Ali

Yiu Chung Lau

Songwei Shan

Sukhyun Ryu

Zhanwei Du

Lin Wang

Xiao-Ke Xu

Dongxuan Chen

Jiaming Xiong

Jungyeon Tae

Tim K Tsang

Peng Wu

Eric H Y Lau

Benjamin J Cowling

Affiliations

Soon will be listed here.

Abstract

Background: The transmission dynamics of influenza were affected by public health and social measures (PHSMs) implemented globally since early 2020 to mitigate the COVID-19 pandemic. We aimed to assess the effect of COVID-19 PHSMs on the transmissibility of influenza viruses and to predict upcoming influenza epidemics.

Methods: For this modelling study, we used surveillance data on influenza virus activity for 11 different locations and countries in 2017-22. We implemented a data-driven mechanistic predictive modelling framework to predict future influenza seasons on the basis of pre-COVID-19 dynamics and the effect of PHSMs during the COVID-19 pandemic. We simulated the potential excess burden of upcoming influenza epidemics in terms of fold rise in peak magnitude and epidemic size compared with pre-COVID-19 levels. We also examined how a proactive influenza vaccination programme could mitigate this effect.

Findings: We estimated that COVID-19 PHSMs reduced influenza transmissibility by a maximum of 17·3% (95% CI 13·3-21·4) to 40·6% (35·2-45·9) and attack rate by 5·1% (1·5-7·2) to 24·8% (20·8-27·5) in the 2019-20 influenza season. We estimated a 10-60% increase in the population susceptibility for influenza, which might lead to a maximum of 1-5-fold rise in peak magnitude and 1-4-fold rise in epidemic size for the upcoming 2022-23 influenza season across locations, with a significantly higher fold rise in Singapore and Taiwan. The infection burden could be mitigated by additional proactive one-off influenza vaccination programmes.

Interpretation: Our results suggest the potential for substantial increases in infection burden in upcoming influenza seasons across the globe. Strengthening influenza vaccination programmes is the best preventive measure to reduce the effect of influenza virus infections in the community.

Funding: Health and Medical Research Fund, Hong Kong.

Citing Articles

Vaccine effectiveness against influenza B/Victoria-associated medically attended influenza-like illness: Beijing, China, 2021-2022 influenza season.

Ma C, Sun Y, Zhang L, Zhang J, Duan W, Li J Hum Vaccin Immunother. 2025; 21(1):2460859.

PMID: 39971488 PMC: 11844929. DOI: 10.1080/21645515.2025.2460859.

Assessment of the impacts of public health and social measures on influenza activity during the COVID-19 pandemic from 2020 to 2022 in Beijing, China: a modelling study.

Du J, Jia L, Gao Y, Su J, Wang C, Pang X BMC Infect Dis. 2025; 25(1):150.

PMID: 39891052 PMC: 11786347. DOI: 10.1186/s12879-025-10505-5.

Quantitative assessment of Public Health and Social Measures implementation and relaxation on influenza transmission during COVID-19 in China: SEIABR and GBDT models.

He Y, Luo K, Ni H, Kuang W, Fu L, Yi S J Glob Health. 2024; 14:05038.

PMID: 39727104 PMC: 11672222. DOI: 10.7189/jogh.14.05038.

An adaptive weight ensemble approach to forecast influenza activity in an irregular seasonality context.

Tsang T, Du Q, Cowling B, Viboud C Nat Commun. 2024; 15(1):8625.

PMID: 39366942 PMC: 11452387. DOI: 10.1038/s41467-024-52504-1.

Parental Hesitancy toward Seasonal Influenza Vaccination for Children under the Age of 18 Years and Its Determinants in the Post-Pandemic Era: A Cross-Sectional Survey among 1175 Parents in China.

Cao H, Chen S, Liu Y, Zhang K, Fang Y, Chen H Vaccines (Basel). 2024; 12(9).

PMID: 39340020 PMC: 11435664. DOI: 10.3390/vaccines12090988.

References

Ionides E, Breto C, Park J, Smith R, King A . Monte Carlo profile confidence intervals for dynamic systems. J R Soc Interface. 2017; 14(132. PMC: 5550967. DOI: 10.1098/rsif.2017.0126. View

Wong J, Wu P, Nishiura H, Goldstein E, Lau E, Yang L . Infection fatality risk of the pandemic A(H1N1)2009 virus in Hong Kong. Am J Epidemiol. 2013; 177(8):834-40. PMC: 3658096. DOI: 10.1093/aje/kws314. View

Baker R, Park S, Yang W, Vecchi G, Metcalf C, Grenfell B . The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections. Proc Natl Acad Sci U S A. 2020; 117(48):30547-30553. PMC: 7720203. DOI: 10.1073/pnas.2013182117. View

Sullivan S, Carlson S, Cheng A, Chilver M, Dwyer D, Irwin M . Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020. Euro Surveill. 2020; 25(47). PMC: 7693168. DOI: 10.2807/1560-7917.ES.2020.25.47.2001847. View

Gao H, Du Z, Tsang T, Xiao J, Shan S, Liao Q . Pandemic fatigue and attenuated impact of avoidance behaviours against COVID-19 transmission in Hong Kong by cross-sectional telephone surveys. BMJ Open. 2021; 11(12):e055909. PMC: 8688730. DOI: 10.1136/bmjopen-2021-055909. View

Olsen S, Winn A, Budd A, Prill M, Steel J, Midgley C . Changes in influenza and other respiratory virus activity during the COVID-19 pandemic-United States, 2020-2021. Am J Transplant. 2021; 21(10):3481-3486. PMC: 8653380. DOI: 10.1111/ajt.16049. View

Davies N, Kucharski A, Eggo R, Gimma A, Edmunds W . Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study. Lancet Public Health. 2020; 5(7):e375-e385. PMC: 7266572. DOI: 10.1016/S2468-2667(20)30133-X. View

Li Y, Campbell H, Kulkarni D, Harpur A, Nundy M, Wang X . The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries. Lancet Infect Dis. 2021; 21(2):193-202. PMC: 7581351. DOI: 10.1016/S1473-3099(20)30785-4. View

Haug N, Geyrhofer L, Londei A, Dervic E, Desvars-Larrive A, Loreto V . Ranking the effectiveness of worldwide COVID-19 government interventions. Nat Hum Behav. 2020; 4(12):1303-1312. DOI: 10.1038/s41562-020-01009-0. View

10.

Qi Y, Shaman J, Pei S . Quantifying the Impact of COVID-19 Nonpharmaceutical Interventions on Influenza Transmission in the United States. J Infect Dis. 2021; 224(9):1500-1508. PMC: 8522386. DOI: 10.1093/infdis/jiab485. View

11.

Meyer D, Shearer M, Chih Y, Hsu Y, Lin Y, Nuzzo J . Taiwan's Annual Seasonal Influenza Mass Vaccination Program-Lessons for Pandemic Planning. Am J Public Health. 2018; 108(S3):S188-S193. PMC: 6129648. DOI: 10.2105/AJPH.2018.304527. View

12.

Essaidi-Laziosi M, Alvarez C, Puhach O, Sattonnet-Roche P, Torriani G, Tapparel C . Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract. Emerg Microbes Infect. 2021; 11(1):412-423. PMC: 8803056. DOI: 10.1080/22221751.2021.2021806. View

13.

Cowling B, Ali S, Ng T, Tsang T, Li J, Fong M . Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study. Lancet Public Health. 2020; 5(5):e279-e288. PMC: 7164922. DOI: 10.1016/S2468-2667(20)30090-6. View

14.

Wan W, Thoon K, Loo L, Chan K, Oon L, Ramasamy A . Trends in Respiratory Virus Infections During the COVID-19 Pandemic in Singapore, 2020. JAMA Netw Open. 2021; 4(6):e2115973. PMC: 8239970. DOI: 10.1001/jamanetworkopen.2021.15973. View

15.

Groves H, Piche-Renaud P, Peci A, Farrar D, Buckrell S, Bancej C . The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada: A population-based study. Lancet Reg Health Am. 2021; 1:100015. PMC: 8285668. DOI: 10.1016/j.lana.2021.100015. View

16.

Ali S, Cowling B . Influenza Virus: Tracking, Predicting, and Forecasting. Annu Rev Public Health. 2020; 42:43-57. DOI: 10.1146/annurev-publhealth-010720-021049. View

17.

Soltesz K, Gustafsson F, Timpka T, Jalden J, Jidling C, Heimerson A . The effect of interventions on COVID-19. Nature. 2020; 588(7839):E26-E28. DOI: 10.1038/s41586-020-3025-y. View

18.

Ali S, Cowling B, Lau E, Fang V, Leung G . Mitigation of Influenza B Epidemic with School Closures, Hong Kong, 2018. Emerg Infect Dis. 2018; 24(11):2071-2073. PMC: 6200008. DOI: 10.3201/eid2411.180612. View

19.

Fonville J, Wilks S, James S, Fox A, Ventresca M, Aban M . Antibody landscapes after influenza virus infection or vaccination. Science. 2014; 346(6212):996-1000. PMC: 4246172. DOI: 10.1126/science.1256427. View

20.

Feng L, Zhang T, Wang Q, Xie Y, Peng Z, Zheng J . Impact of COVID-19 outbreaks and interventions on influenza in China and the United States. Nat Commun. 2021; 12(1):3249. PMC: 8167168. DOI: 10.1038/s41467-021-23440-1. View